hsa-mir-1237: Hsa-mir-1237 is a miRNA that has been found to have a binding site in all brain tissues examined [PMC4028873]. It is one of the four miRNAs, along with hsa-miR-1978, hsa-miR-933, and hsa-miR-889, that were not previously reported to have roles in ovarian cancer [PMC8148489]. However, further analysis revealed that hsa-mir-1237, along with hsa-miR-933 and hsa-miR-889, were significantly associated with overall survival in patients with ovarian cancer [PMC8148489]. In a study on CACO-2 cells and CW-2 cells, the expression levels of hsa-mir-1237 were found to be significantly changed after treatment with Gal-9 [PMC8072828]. Hsa-mir-1237 was also commonly altered in CACO-2 cells and CW-2 cells both in vitro and in vivo [PMC8072828]. Additionally, it was identified as a miRNA of mirtron origin processed from intron 11 of the RPS6KA4 gene [PMC5932543]. PsRNA-seq was used as a highly sensitive technique to detect low amounts of mature miRNAs like has-miR21 star and hsa-mir1237 [PMC5932543].